Comparative Study of Twelve Versus Twenty-Four Hours Magnesium Sulphate Regimens for Prevention of Postpartum Eclampsia in Preeclamptics with Severe Features.
Not Applicable
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR202401609294319
- Lead Sponsor
- niversity of Ilorin Teaching Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 84
Inclusion Criteria
1.Pregnant women at gestational age = 28 weeks with live intrauterine fetus(es) scheduled for delivery or in labour.
2.Clinical diagnosis of preeclampsia with severe features using the American College of Obstetrics and Gynaecology (ACOG) as stated in the introduction.
Exclusion Criteria
1.Comorbid maternal diagnosis of renal disease and/or seizure disorder.
2.Contraindication to MgSO4 (drug hypersensitivity, myasthenia gravis, anuria or oliguria i.e., urine output less than 25ml/hour).
3.Prior administration of any other anticonvulsants (e.g., Diazepam, phenytoin) within 24 hours before recruitment.
4.Prior administration of MgSO4 within 72 hours which is not a component of the study regimens.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method